VW VWR 로딩 중... : 애널리스트의 강세 및 약세 의견

The company saw pharma customer organic growth of low single digits and academic/government decline of low single digits in Q4, with no budget flush observed, indicating the pharma recovery is still in early, cautious stages. — Improvement is based on policy clarity, not a burst of year-end spending, suggesting a slower, more durable recovery rather than a sharp snapback.